Delivering better treatments
Camurus is committed to improving the lives of patients
with severe and chronic diseases
Focus on severe and chronic diseases
Developing treatments for diseases within the central nervous system, rare diseases, endocrinology, oncology and supportive care
Jefferies Healthcare Conference
Camurus’ President & CEO Fredrik Tiberg is presenting at Jefferies Healthcare Conference New York 2023 on Thursday 8 June, 1.30pm EDT. Webcast
Interim Report January-June 2023
The interim report January-June is published on 18 July 2023.
Interim Report January-September 2023
The interim report January-September is published on 9 November 2023.
Latest financial report
Camurus’ Interim Report January-March 2023
10 May 2023
- Report Camurus’ Interim Report January-March 2023
- Presentation Camurus’ Interim Report January-March 2023
- Audiocast Camurus’ Interim Report January-March 2023
Annual General Meeting
Camurus' Annual General Meeting 2023 took place on 10 May 2023 at 17.00 CEST at Elite Hotel Ideon, Scheelevägen 27, 223 63 Lund, Sweden.
Resolutions at the annual general meeting 2023
General meeting documents
Diversified pipeline with large potential
Camurus' innovative product candidates are designed to address important unmet medical needs, with the potential to make significant difference in the daily life of patients by improving treatment outcomes, quality of life, and long-term recovery.
Sustainable solutions for a healthier world
Ensuring the long-term successful development of our business – for the benefit of patients, healthcare systems, employees and shareholders